Patents by Inventor Mana Mirza

Mana Mirza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Grading, staging, and prognosing cancer using osteopontin-c
    Patent number: 10934591
    Abstract: The present disclosure provides methods and kits that can be used to determine the grade or stage of a breast or other cancer, such as a ductal carcinoma in situ (DCIS). By determining the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regiments can be selected and administered to the patient with the cancer. The method includes detecting osteopontin-c (OPN-c), wherein the presence of high amounts of OPN-c in the cancer sample indicates that the subject has a more aggressive form of cancer (e.g., grade 3).
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: March 2, 2021
    Assignees: VENTANA MEDICAL SYSTEMS, INC., UNIVERSITY OF CINCINNATI
    Inventors: Mana Mirza, Elizabeth Shaughnessy, John K. Hurley, Kristie A. Vanpatten, Gary Pestano, Georg F. Weber
  • GRADING, STAGING, AND PROGNOSING CANCER USING OSTEOPONTIN-C
    Publication number: 20180119232
    Abstract: The present disclosure provides methods and kits that can be used to determine the grade or stage of a breast or other cancer, such as a ductal carcinoma in situ (DCIS). By determining the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regiments can be selected and administered to the patient with the cancer. The method includes detecting osteopontin-c (OPN-c), wherein the presence of high amounts of OPN-c in the cancer sample indicates that the subject has a more aggressive form of cancer (e.g., grade 3).
    Type: Application
    Filed: December 13, 2017
    Publication date: May 3, 2018
    Inventors: Mana Mirza, Elizabeth Shaughnessy, John K. Hurley, Kristie A. Vanpatten, Gary Pestano, Georg F. Weber
  • Grading, staging and prognosing cancer using osteopontin-C
    Patent number: 9873915
    Abstract: The present disclosure provides methods and kits that can be used to determine the grade or stage of a breast or other cancer, such as a ductal carcinoma in situ (DCIS). By determining the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regiments can be selected and administered to the patient with the cancer. The method includes detecting osteopontin-c (OPN-c), wherein the presence of high amounts of OPN-c in the cancer sample indicates that the subject has a more aggressive form of cancer (e.g., grade 3).
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: January 23, 2018
    Assignees: Ventana Medical Systems, Inc., University of Cincinnati
    Inventors: Mana Mirza, Elizabeth Shaughnessy, Georg F. Weber, John K. Hurley, Kristie A. Vanpatten, Gary Pestano
  • Grading, Staging and prognosing Cancer using Osteopontin-C
    Publication number: 20100209928
    Abstract: The present disclosure provides methods and kits that can be used to determine the grade or stage of a breast or other cancer, such as a ductal carcinoma in situ (DCIS). By determining the grade, stage, or aggressiveness of a cancer, appropriate therapeutic regiments can be selected and administered to the patient with the cancer. The method includes detecting osteopontin-c (OPN-c), wherein the presence of high amounts of OPN-c in the cancer sample indicates that the subject has a more aggressive form of cancer (e.g., grade 3).
    Type: Application
    Filed: October 16, 2008
    Publication date: August 19, 2010
    Inventors: Mana Mirza, Elizabeth Shaughnessy, Georg F. Weber, John K. Hurley, Kristie A. Vanpatten, Gary Pestano